Epigenetic Control of Human Trophoblast Stem Cell Differentiation

人类滋养层干细胞分化的表观遗传控制

• 批准号: 10041641
• 负责人: Micah Gearhart
• 金额: $ 19.26万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-03 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10041641
• 关键词: Affect; Biological Assay; Biological Markers; Birth; CRISPR/Cas technology; Cardiovascular system; Cell Differentiation process; Cell Line; Cell Lineage; Cell fusion; Cells; Chromatin; Chronic; Complex; Congenital Abnormality; DNA Sequence Alteration; Defect; Derivation procedure; Diagnosis; Disease; Early Diagnosis; Epigenetic Process; Event; Exhibits; Female; Fetal Growth; Fetal Growth Retardation; Fetal Mortality Statistics; Fetus; Flow Cytometry; Gene Expression; Generations; Genes; Genetic; Genetic Transcription; Genetic study; Giant Cells; Goals; Habitual Abortion; Health; Human; Human Genetics; In Vitro; Infertility; Knock-in; Labyrinth; Lead; Life; Link; Low Birth Weight Infant; Maternal Mortality; Matrigel Invasion Assay; Missense Mutation; Modeling; Molecular; Mosaicism; Mothers; Mus; Mutate; Mutation; Neurologic; Nucleotides; Organ; PRC1 Protein; Pathology; Pathway interactions; Patients; Phenotype; Placenta; Placentation; Play; Point Mutation; Pregnancy; Pregnancy Complications; Pregnancy loss; Process; Proteins; Recurrence; Regulation; Research; Role; Syncytiotrophoblast; Syndrome; System; Testing; Woman; Work; X Inactivation; cell fate specification; cell type; clinically relevant; early detection biomarkers; epigenetic regulation; epigenome; experience; genome-wide; insight; mRNA Expression; male; matrigel; mouse genetics; mutant; novel; null mutation; potential biomarker; progenitor; promoter; protein function; self-renewal; single-cell RNA sequencing; stem cell differentiation; stem cells; stillbirth; trophoblast

Placentation requires faithful allocation and differentiation of trophoblast stem cells into diverse cell types, creating an organ capable of sustaining the fetus. Defects in this process can have dire consequences for both the fetus and the mother and can contribute to infertility, recurrent miscarriages and stillbirth. Abnormal fetal growth caused by placental defects can also have chronic effects throughout life. This proposal will generate insights into the epigenetic events that control human trophoblast differentiation essential for understanding the origin and pathology of placental defects. Genetic studies in mice have identified regulators of trophoblast differentiation but their clinical relevance is uncertain due to differences between mice and humans. The derivation of human trophoblast stem (hTS) cells, which are able to recapitulate early trophoblast differentiation in vitro, represents a transformational advance. This culture system provides an incisive means to investigate the effects of genetic mutations in human trophoblasts. These studies will use hTS cells to ask whether regulators identified in the mouse are crucial for human trophoblast differentiation. The long-term goal of the proposed work is to identify genetic and epigenetic factors that promote normal placental development in humans. This application focuses on BCOR, an X-linked gene with essential roles in placental development in mice. BCOR is mutated in human syndromes involving low birth weight and intrauterine growth restriction (IUGR) and women with a heterozygous null mutation in BCOR can experience recurrent miscarriages. BCOR is a conserved component of the epigenetic silencing complex Polycomb Repressive Complex 1.1. The central hypothesis of this proposal is that BCOR is a key epigenetic regulator of human placental development. The proposed work has two specific aims. The first investigates whether BCOR regulates human trophoblast differentiation by introducing into hTS cells BCOR null mutations found in human patients that might be responsible for the associated IUGR and recurrent miscarriages. Phenotypic assays will determine whether these mutations affect the ability of trophoblast stem cells to differentiate into syncytiotrophoblast and extravillous trophoblasts cell types, which play important functional roles in placentation. BCOR-dependent mRNA expression and epigenetic changes will be used to identify key downstream targets that affect trophoblast differentiation and might encode useful biomarkers for early diagnosis of pregnancy complications arising from improper trophoblast differentiation. The second aim investigates the functional importance of BCOR missense mutations, asking how they affect function of the protein. Characterization of missense mutations in the BCOR protein will provide mechanistic insights into how it influences trophoblast differentiation and will have an impact that extends beyond the patients with these syndromes.

胎盘形成需要滋养层干细胞的忠实分配和分化成不同的细胞类型，创造一个能够维持胎儿的器官。这一过程中的缺陷可能对胎儿和母亲都产生可怕的后果，并可能导致不孕症，经常性流产和死胎。由胎盘缺陷引起的胎儿生长异常也会对一生产生慢性影响。这一建议将产生洞察到控制人类滋养层细胞分化的表观遗传事件，了解胎盘缺陷的起源和病理学至关重要。小鼠的遗传研究已经确定了滋养层分化的调节因子，但由于小鼠和人类之间的差异，其临床相关性尚不确定。人类滋养层干细胞（hTS）的衍生能够在体外重现早期滋养层分化，代表了一个变革性的进展。这种培养系统为研究人类滋养层细胞基因突变的影响提供了一种精辟的手段。这些研究将使用hTS细胞来询问在小鼠中鉴定的调节剂是否对人类滋养层分化至关重要。这项工作的长期目标是确定促进人类正常胎盘发育的遗传和表观遗传因素。本申请的重点是BCOR，一个X连锁基因在小鼠胎盘发育中具有重要作用。BCOR在涉及低出生体重和宫内生长受限（IUGR）的人类综合征中发生突变，BCOR杂合无效突变的女性可能会经历复发性流产。BCOR是表观遗传沉默复合物Polycomb Repressive Complex 1.1的保守组分。该建议的中心假设是BCOR是人类胎盘发育的关键表观遗传调节因子。拟议的工作有两个具体目标。第一个研究是否BCOR调节人类滋养层细胞的分化，通过引入hTS细胞BCOR无效突变，在人类患者中发现，可能是相关的IUGR和复发性流产负责。表型分析将确定这些突变是否影响滋养层干细胞分化为合体滋养层和绒毛外滋养层细胞类型的能力，这些细胞类型在胎盘形成中发挥重要的功能作用。BCOR依赖的mRNA表达和表观遗传变化将用于识别影响滋养层分化的关键下游靶点，并可能编码有用的生物标志物，用于早期诊断由滋养层分化不当引起的妊娠并发症。第二个目的是研究BCOR错义突变的功能重要性，询问它们如何影响蛋白质的功能。BCOR蛋白中错义突变的表征将提供关于其如何影响滋养层分化的机制性见解，并将产生超出这些综合征患者范围的影响。